egtazic acid has been researched along with Cytomegalovirus Infections in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hjortø, GM; Kiilerich-Pedersen, K; Kledal, TN; Larsen, NB; Selmeczi, D | 1 |
| Brauner, P; Fridlender, B | 1 |
2 other study(ies) available for egtazic acid and Cytomegalovirus Infections
| Article | Year |
|---|---|
Human cytomegalovirus chemokine receptor US28 induces migration of cells on a CX3CL1-presenting surface.
Topics: Cell Movement; Cells, Cultured; Chelating Agents; Chemokine CX3CL1; Chemokines, CC; CX3C Chemokine Receptor 1; Cytomegalovirus; Cytomegalovirus Infections; Dose-Response Relationship, Drug; Egtazic Acid; Endothelial Cells; Estrenes; GTP-Binding Proteins; HEK293 Cells; Humans; Membrane Proteins; Mutation; Phosphodiesterase Inhibitors; Phospholipase C beta; Pyrrolidinones; Receptors, Chemokine; Signal Transduction; Time-Lapse Imaging; Viral Proteins | 2013 |
Use of chelating agents as terminators of alkaline phosphatase activity in enzyme-linked immunosorbent assay (ELISA) tests.
Topics: Alkaline Phosphatase; Chelating Agents; Cysteine; Cytomegalovirus Infections; Edetic Acid; Egtazic Acid; Enzyme-Linked Immunosorbent Assay; Humans | 1981 |